UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000013007 |
|---|---|
| Receipt number | R000015180 |
| Scientific Title | Clinical trial of botulinum toxin type A therapy in patients with Japanese cedar pollinosis 2014 |
| Date of disclosure of the study information | 2014/02/10 |
| Last modified on | 2017/10/03 19:40:28 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Clinical trial of botulinum toxin type A therapy in patients with Japanese cedar pollinosis 2014
Acronym
Effect of Botulinum Toxin Type A Therapy in Patients with Jananese cedar polloniosis(E-Boat study 4)
Scientific Title
Clinical trial of botulinum toxin type A therapy in patients with Japanese cedar pollinosis 2014
Scientific Title:Acronym
Effect of Botulinum Toxin Type A Therapy in Patients with Jananese cedar polloniosis(E-Boat study 4)
Region
| Japan |
Condition
Condition
Japanese cedar pollinosis
Classification by specialty
| Oto-rhino-laryngology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigae the efficacy and safety of botulinum toxin type A in patients with Japanese cedar pollinosis
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Pragmatic
Developmental phase
Assessment
Primary outcomes
Symptom score, Symptom-Medication score, Numeric Rating Scale
Key secondary outcomes
Adverse events
Medication Score
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
NO
Dynamic allocation
NO
Institution consideration
Institution is considered as a block.
Blocking
YES
Concealment
Central registration
Intervention
No. of arms
2
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
One-point-six ml (40U) of botulinum toxin type A soaked cotton sponge is inserted into each nostril and placed on nasa mucosa for 15 to 20min, then removed. anti-histamine tablet and/or eye drops can be used as backup drugs.
Interventions/Control_2
One-point-six ml saline soaked cotton sponge is inserted into each nostril and placed on nasa mucosa for 15 to 20min, then removed. anti-histamine tablet and/or eye drops can be used as backup drugs.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 65 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
a history of Japnese cedar pollinosis in each year and CAP-RAST ageinst Japanese cedar pollen >=2
Key exclusion criteria
1)pregnacy
2)during breast feeding
3)history of heart disease
4)history of neuro-muscular disease
5)history of nasal surgery
6)prominent deviation of the nasal septum
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Atsushi Kamijo |
Organization
Saitama Medical University
Division name
Otorhinolaryngology, Allergy Center
Zip code
Address
38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, Japan
TEL
049-276-1253
atkamijo@saitama-med.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | A |
Organization
Saitama Medical University
Division name
Otorhinolaryngology
Zip code
Address
38 Morohongo, Moroyama-machi, Iruma-gun, Saitama, Japan
TEL
049-276-1253
Homepage URL
atkamijo@saitama-med.ac.jp
Sponsor or person
Institute
Saitama Medical University
Institute
Department
Personal name
Funding Source
Organization
Dept Otorhinolarngology and Allergy Center, Saitama Medical University
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2014 | Year | 02 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 01 | Month | 26 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 02 | Month | 15 | Day |
Last follow-up date
| 2014 | Year | 05 | Month | 31 | Day |
Date of closure to data entry
| 2015 | Year | 07 | Month | 31 | Day |
Date trial data considered complete
| 2015 | Year | 07 | Month | 31 | Day |
Date analysis concluded
| 2015 | Year | 12 | Month | 31 | Day |
Other
Other related information
Management information
Registered date
| 2014 | Year | 01 | Month | 29 | Day |
Last modified on
| 2017 | Year | 10 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015180
